Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L36a pseudogene 25 (RPL36AP25) is a human processed pseudogene, meaning it is a non-functional copy of a protein-coding gene, specifically derived from the parental ribosomal protein L36a gene. It resides on chromosome 17 and, like other processed pseudogenes, does not encode a functional protein but may potentially play roles in gene regulation at the RNA level, such as acting as a competing endogenous RNA or miRNA sponge; however, there is no direct evidence for this specific pseudogene. RPL36AP25 is not considered a therapeutic target and has no known direct roles in disease, drug interactions, or established functions beyond being a genomic relic and potential regulatory RNA.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L36a pseudogene 25 (RPL36AP25).